Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, Council of Advisors on Science and Technology

September 6, 2023
Share on LinkedIn Share on Twitter Share on Facebook

Informing Public Health Decisions with Data and Science: Sue Desmond-Hellmann, M.D., Member, Council of Advisors on Science and Technology & Former CEO, Bill & Melinda Gates Foundation

In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical trials, the implications of the Inflation Reduction Act on the pharmaceutical industry and the influence of science in public health and policymaking.

Want more insights on the people, stories and ideas that are changing healthcare into what it should be? Subscribe to our Healthcare Connection newsletter and get transformative ideas delivered to your inbox every month.

Dive Deeper

The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant
  • Activation
  • Analytics + Insights
  • Artificial Intelligence

The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant

October 21, 2025
The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant
  • Activation
  • Analytics + Insights
  • Artificial Intelligence

The FDA Is Raising the Stakes — Here’s How We’re Helping Brands Stay Creative and Compliant

October 21, 2025
Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond
  • Activation

Real Chemistry Strengthens Media and Omnichannel Leadership with Acquisition of Spring & Bond

October 15, 2025